Marshall Wace, LLP Tandem Diabetes Care Inc Transaction History
Marshall Wace, LLP
- $72.2 Billion
- Q2 2024
A detailed history of Marshall Wace, LLP transactions in Tandem Diabetes Care Inc stock. As of the latest transaction made, Marshall Wace, LLP holds 524,393 shares of TNDM stock, worth $22.3 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
524,393
Previous 3,120,374
83.19%
Holding current value
$22.3 Million
Previous $110 Million
80.88%
% of portfolio
0.03%
Previous 0.17%
Shares
21 transactions
Others Institutions Holding TNDM
# of Institutions
344Shares Held
72.7MCall Options Held
3.12MPut Options Held
343K-
Black Rock Inc. New York, NY11.1MShares$472 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.38MShares$313 Million0.01% of portfolio
-
Capital World Investors Los Angeles, CA3.67MShares$156 Million0.02% of portfolio
-
State Street Corp Boston, MA2.57MShares$109 Million0.0% of portfolio
-
Arrow Mark Colorado Holdings LLC Denver, CO2.5MShares$106 Million1.33% of portfolio
About TANDEM DIABETES CARE INC
- Ticker TNDM
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 64,221,200
- Market Cap $2.73B
- Description
- Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin c...